Haffner retiring from FDA to join Amgen

The FDA's director of orphan products development for the past 19 years, Marlene Haffner, will retire in January to join the biotech firm Amgen as director of its government affairs office in Washington.
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.